This type of breast cancer is characterised by a resistance to hormonal and anti-HER therapy since it lacks for oestrogenic and progesterone receptor (ER and PR), also it has low expression level of human epidermal growth factor receptor 2 (HER-2).3 This evidence concerns the gene PGR and breast cancer.